Verition Fund Management’s ResMed RMD Stock Holding History

Verition Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,600	Closed	-$2.37M	–	2247
2021 Q2	$2.37M	Buy	+9,600	New	+$2.02M	0.02%	469

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Verition Fund Management's RMD Position: Q2 2026 in Review

Verition Fund Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 22,394 shares — an estimated $5.03M sold.

Verition Fund Management first reported a position in RMD in Q2 2013 and held it in 28 quarters. The position peaked at $5.94M in Q2 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Verition Fund Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Verition Fund Management sold 22,394 ResMed shares in Q2 2026, an estimated $5.03M.
Verition Fund Management first reported a position in ResMed in Q2 2013 and held it in 28 quarters.
Verition Fund Management's ResMed position peaked at $5.94M in Q2 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.